Notification Regarding Health Products Containing Carbomers

Posted Date: 24-February-2026

SCCS Mandate on Hydroxycitronellal and Glyoxylic Acid

 

In alignment with the U.S. FDA’s alerts regarding benzene risk, the NNHPD has revised several entries in the Natural Health Products Ingredients Database (NHPID). Benzene is a Class I solvent with unacceptable toxicity and must not be used in health product manufacturing.

 

Key Changes:

 

  • Ingredients Removed: Carbomer 934, 934P, 940, 941, and 1342 (as these may be manufactured using benzene).
  • Generic Entry Removed: The generic “carbomer” entry is now insufficient; specific viscosity grades must be identified.
  • Regulatory Alignment: The USP and NF have proposed omitting these specific carbomer monographs effective August 1, 2026.

 

The NNHPD is contacting approximately 865 NHP licence holders and 70 non-prescription drug licence holders to request the removal of these carbomers from formulations by the August 2026 deadline. Please find below the summary of updates to Carbomer in the NHPID.

 

Updates to carbomer entries